| Literature DB >> 29439323 |
Stina Leskelä1, Mari Takalo1,2, Mikael Marttinen2, Nadine Huber1, Jussi Paananen2, Vikram Mitra3, Tuomas Rauramaa4,5, Petra Mäkinen2, Ville Leinonen6, Hilkka Soininen7,8, Ian Pike3, Anne M Remes7,8, Mikko Hiltunen2,7,8, Annakaisa Haapasalo1,8.
Abstract
A subset of C9orf72 repeat expansion-carrying frontotemporal dementia patients display an Alzheimer-like decrease in cerebrospinal fluid amyloid-β (Aβ) biomarker levels. We report that downregulation of C9orf72 in non-neuronal human cells overexpressing amyloid-β protein precursor (AβPP) resulted in increased levels of secreted AβPP fragments and Aβ, while levels of AβPP or its C-terminal fragments (CTFs) remained unchanged. In neuronal cells, AβPP and C83 CTF levels were decreased upon C9orf72 knockdown, but those of secreted AβPP fragments or Aβ remained unchanged. C9orf72 protein levels significantly increased in human brain with advancing neurofibrillary pathology and positively correlated with brain Aβ42 levels. Our data suggest that altered C9orf72 levels may lead to cell-type specific alterations in AβPP processing, but warrant further studies to clarify the underlying mechanisms.Entities:
Keywords: Alzheimer’s disease; C9orf72; amyloid-β; amyloid-β protein precursor; frontotemporal dementia
Mesh:
Substances:
Year: 2018 PMID: 29439323 DOI: 10.3233/JAD-170362
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472